Burzynski Clinic
Houston, Texas 77055-6330
0 studies enrolling now · 62 studies all time
What they study most
Adenocarcinoma of the Colon, Adenocarcinoma of the Esophagus, Adenocarcinoma of the Prostate, Adult Brain Tumor, Anaplastic Astrocytoma, Brain Stem Gliomas, Bronchial Alveolar; Tumor, CNS Tumor, Cervical Cancer Stage IV, Childhood Brain Tumor, Childhood Brain Tumors, Childhood CNS Primitive Neuroectodermal Tumor
Studies at this site
- A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) — Paused
- Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma — Completed
- Antineoplaston Therapy in Treating Children With Brain Tumors — Completed
- Antineoplaston Therapy in Treating Patients With Ependymoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Multiple Myeloma — Stopped early
- Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus — Stopped early
- Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma — Stopped early
- Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Stage IV Melanoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin — Stopped early
- Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma — Completed
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme — Completed
- Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme — Completed
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma — Stopped early
- Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma — Stopped early
- Antineoplaston Therapy in Treating Patients With Brain Stem Glioma — Completed
- Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia — Withdrawn before enrolling
- Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer — Withdrawn before enrolling
- Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas — Completed
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Primary Liver Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva — Stopped early
- Antineoplaston Therapy in Treating Patients With Stomach Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine — Stopped early
- Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors — Stopped early
- Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma — Stopped early
- Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer — Stopped early
- Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer — Stopped early
- Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer — Stopped early
- Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder — Stopped early
- Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors — Completed
- Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma — Completed
- Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors — Completed
- Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors — Stopped early
- Antineoplaston Therapy in Treating Children With Visual Pathway Glioma — Completed